Chengping Hu

14.5k total citations · 2 hit papers
195 papers, 5.8k citations indexed

About

Chengping Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chengping Hu has authored 195 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pulmonary and Respiratory Medicine, 68 papers in Molecular Biology and 63 papers in Oncology. Recurrent topics in Chengping Hu's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (27 papers) and Asthma and respiratory diseases (21 papers). Chengping Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (27 papers) and Asthma and respiratory diseases (21 papers). Chengping Hu collaborates with scholars based in China, United States and Germany. Chengping Hu's co-authors include Yi‐Long Wu, Shun Lü, Caicun Zhou, Jifeng Feng, Mei Hou, Jian Hua Shi, Yunchao Huang, Dan Massey, Sarayut Lucien Geater and Wěi Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Chengping Hu

184 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

2014 1.6k citations Yi‐Long Wu, Chengping Hu et al. profile →
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

2019 265 citations Yi‐Long Wu, Shun Lü et al. profile →

Peers

Countries citing papers authored by Chengping Hu

Since Specialization

Citations

This map shows the geographic impact of Chengping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengping Hu more than expected).

Fields of papers citing papers by Chengping Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengping Hu. The network helps show where Chengping Hu may publish in the future.

Co-authorship network of co-authors of Chengping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengping Hu. A scholar is included among the top collaborators of Chengping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengping Hu. Chengping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2225P Tissue factor (TF) antibody-drug conjugate (ADC) MRG004A in patients (pts) with advanced pancreatic cancer (PC): Updated results from a phase I study 2025 ·Annals of Oncology ·Weizheng Ren, Wonse Park, Xin Yu, Jun Shan, Huijuan Wu, Hong Zhao, Chengping Hu, Justin Tang, James C. Yang, Zuoxing Niu, (unknown), Ye Li, Zhengtao Wang	0
2	MASH1 induces neuron transdifferentiation of adrenal medulla chromaffin cells. 2023 ·PubMed ·(unknown), Chengping Hu, (unknown), Ruoxi He	0
3	Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia 2023 ·Immunotherapy ·Ying Cheng, James C. Yang, Isamu Okamoto, Li Zhang, Jie Hu, Donglin Wang, Chengping Hu, Jianying Zhou, Lin Wu, Lejie Cao, Jiwei Liu, Helong Zhang, Hong Sun, Ziping Wang, Hongjun Gao, Yan Yan, (unknown), Jianxin Lin, M. Catherine Pietanza, Takayasu Kurata	3
4	Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study 2023 ·Therapeutic Advances in Respiratory Disease ·Rongli Lu, Ying Li, Chengping Hu, Pinhua Pan, (unknown), Ruoxi He	1
5	693P Preclinical activity of HLX43, a PD-L1-targeting ADC, in multiple PD-1/PD-L1 refractory/resistant models 2023 ·Annals of Oncology ·Shan Ye, Rong Liu, (unknown), Huijuan Song, Jizong Jiang, (unknown), Yang Chen, Xin‐hui Yuan, Zongliu Hou, Xiaomeng Wang, Xue Hou, Yimin Shen, Chengping Hu, Hua Wei, Qi Wang, Ji Zhu	0
6	Immune characteristics associated with lymph node metastasis in early-stage NSCLC 2023 ·Cellular Oncology ·Ziyu Zhang, Li Li, Yang Gao, Xiaoxiong Xiao, Liyan Ji, Zhipeng Zhou, (unknown), Shiqing Liu, Jian An, Pengbo Deng, (unknown), Pansong Li, Xuefeng Xia, Chengping Hu, Min� Li	0
7	N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma 2022 ·Gene ·Rongjun Wan, Lu Bai, (unknown), Chengping Hu, Qiong Chen, (unknown), Yan Zhang, Yuanyuan Li	2
8	Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050) 2021 ·Lung Cancer ·Ying Cheng, Tony Mok, Xiangdong Zhou, Shun Lü, Qing Zhou, Jianying Zhou, (unknown), Ping Yu, Xiaoqing Liu, Chengping Hu, You Lü, Yiping Zhang, Ki Hyeong Lee, Kazuhiko Nakagawa, R. Linke, (unknown), Yiyun Tang, (unknown), Keith D. Wilner, Yi‐Long Wu	32
9	The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients 2019 ·Cancer Medicine ·(unknown), Chengping Hu, Li Li, (unknown), (unknown), Han Han‐Zhang, Min Li	31
10	Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy 2018 ·Clinical & Translational Oncology ·Shun Jiang, Chengping Hu, (unknown), Mingzhu Lu	14
11	445P Overall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut): Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) 2015 ·Annals of Oncology ·Yi‐Long Wu, Lecia V. Sequist, Martin Schüler, Nobuyuki Yamamoto, C. Zhou, Chengping Hu, Kenneth J. O’Byrne, Vera Hirsh, Tony Mok, Victoria Zazulina, James Chih‐Hsin Yang	1
12	Lung dendritic cells undergo maturation and polarization towards a T helper type 2-stimulating phenotype in a mouse model of asthma: Role of nerve growth factor 2014 ·Experimental and Therapeutic Medicine ·(unknown), Zhan Wang, Pinhua Pan, (unknown), Qing Xia, Hongyi Tan, Chengping Hu	9
13	Tracheobronchial fungal infections and their bronchoscopic features 2014 ·European Respiratory Journal ·Ruichao Niu, Chengping Hu	2
14	Transforming growth factor-β-induced miR-143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo 2014 ·International Journal of Oncology ·Tianli Cheng, Chengping Hu, Huaping Yang, Liming Cao, Jian An	21
15	Biapenem versus meropenem in the treatment of bacterial infections: a multicenter, randomized, controlled clinical trial. 2013 ·PubMed ·Xiaohui Wang, Xiaoke Zhang, Zhiyong Zong, Ru‐Jia Yu, Xiaoju Lv, Jian‐Bao Xin, (unknown), (unknown), (unknown), Ying Xiong, Hong Liu, Guohua Ding, Chengping Hu	13
16	Tea polyphenols prevent lung from preneoplastic lesions and effect p53 and bcl-2 gene expression in rat lung tissues. 2013 ·PubMed Central ·Qihua Gu, Chengping Hu, Qiong Chen, Ying Xia	13
17	Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor α-mediated mechanisms 2013 ·Oncology Reports ·Mingxuan Xie, Shaojin You, Qiong Chen, Xi Chen, Chengping Hu	26
18	Kidney-Tonifying Recipe Can Repair Alterations in Adrenal Medullary Chromaffin Cells in Asthmatic Rats 2012 ·Evidence-based Complementary and Alternative Medicine ·Chengping Hu, (unknown), (unknown), Xiaozhao Li, (unknown)	3
19	MicroRNA-130a Mediates Proliferation of Vascular Smooth Muscle Cells in Hypertension 2011 ·American Journal of Hypertension ·(unknown), Chengping Hu, (unknown), Weifang Zhang, (unknown), Xiaofang Xiong, (unknown)	85
20	Activation of Lymphocytes Induced by Bronchial Epithelial Cells with Prolonged RSV Infection 2011 ·PLoS ONE ·Ling Qin, Chengping Hu, (unknown), Xia Qian	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact